| Lastest Insider Transactions Of Kymera Therapeutics, Inc. ( KYMR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2024-03-14 | Sell | 127,543 | 40.25 | 5,133,263 | 2024-03-15 19:23:41 |
| KYMR | Kymera Therapeutics, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | 2024-03-11 | Sell | 353,357 | 42.20 | 14,912,376 | 2024-03-13 19:53:50 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2024-03-11 | Sell | 353,357 | 42.20 | 14,912,376 | 2024-03-13 19:52:35 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-03-01 | Sell | 3,344 | 41.86 | 139,967 | 2024-03-04 18:21:23 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2024-03-01 | Sell | 3,934 | 41.86 | 164,664 | 2024-03-04 18:12:04 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-02-20 | Sell | 5,000 | 39.05 | 195,258 | 2024-02-21 18:46:13 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-02-20 | Option Exercise | 5,000 | 10.34 | 51,700 | 2024-02-21 18:46:13 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-02-09 | Sell | 46,137 | 35.50 | 1,638,072 | 2024-02-09 19:47:01 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-02-09 | Option Exercise | 46,137 | 2.08 | 95,965 | 2024-02-09 19:47:01 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-01-23 | Sell | 10,000 | 30.05 | 300,470 | 2024-01-23 19:37:29 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-01-23 | Option Exercise | 10,000 | 10.34 | 103,400 | 2024-01-23 19:37:29 |
| KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | Chief Legal Officer | 2024-01-04 | Sell | 3,295 | 22.58 | 74,416 | 2024-01-05 17:15:06 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2024-01-02 | Option Exercise | 9,000 | 2.08 | 18,720 | 2024-01-02 17:43:37 |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Directior | 2023-11-02 | Buy | 414,105 | 12.80 | 5,301,326 | 2023-11-06 18:07:28 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2023-11-03 | Option Exercise | 20,000 | 2.08 | 41,600 | 2023-11-06 18:00:05 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2023-08-08 | Option Exercise | 12,000 | 2.08 | 24,960 | 2023-08-08 16:30:52 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2023-06-02 | Option Exercise | 10,000 | 2.08 | 20,800 | 2023-06-02 14:17:04 |
| KYMR | Kymera Therapeutics, Inc. | Caughey Elaine | Chief Business Officer | 2023-03-01 | Sell | 714 | 31.00 | 22,132 | 2023-03-03 16:31:17 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2023-03-01 | Sell | 1,298 | 31.00 | 40,233 | 2023-03-03 16:30:52 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2023-03-01 | Sell | 1,370 | 31.00 | 42,465 | 2023-03-03 16:30:13 |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Directior | 2023-01-11 | Buy | 41,007 | 30.51 | 1,251,191 | 2023-01-13 17:08:35 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2023-01-11 | Sell | 126,474 | 30.22 | 3,821,739 | 2023-01-13 16:53:09 |
| KYMR | Kymera Therapeutics, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | 2023-01-11 | Sell | 126,474 | 30.22 | 3,821,739 | 2023-01-13 16:50:44 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2022-12-14 | Sell | 382,244 | 31.36 | 11,985,954 | 2022-12-16 17:05:47 |
| KYMR | Kymera Therapeutics, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | 2022-12-14 | Sell | 382,244 | 31.36 | 11,985,954 | 2022-12-16 17:03:42 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2022-12-08 | Option Exercise | 10,000 | 2.08 | 20,800 | 2022-12-08 18:11:29 |
